These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 31433481)

  • 1. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
    Veluswamy RR; Mhango G; Bonomi M; Neugut AI; Hershman DL; Aldridge MD; Wisnivesky JP
    Ann Am Thorac Soc; 2013 Dec; 10(6):622-8. PubMed ID: 24024700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
    Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the Primary Tumor and Survival in Patients with Single-Site Synchronous Oligometastatic Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Database.
    Rodriguez-Quintero JH; Jindani R; Kamel MK; Zhu R; Vimolratana M; Chudgar NP; Stiles BM
    J Am Coll Surg; 2024 Jun; 238(6):1122-1136. PubMed ID: 38334285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
    Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
    Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base.
    Amini A; Jones BL; Jackson MW; Rusthoven CG; Maroni P; Kavanagh BD; Raben D
    Brachytherapy; 2016; 15(2):136-46. PubMed ID: 26825856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Therapy Plus Thermal Ablation Versus Systemic Therapy Alone for Oligometastatic Liver Metastases from Non-small Cell Lung Cancer.
    Zhao Y; Zhang X; Zhao H; Gong T; Li J; Tsauo J; Li X
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1285-1293. PubMed ID: 32236671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.
    Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V
    Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer.
    Drake JA; Portnoy DC; Tauer K; Weksler B
    Ann Thorac Surg; 2018 Oct; 106(4):959-965. PubMed ID: 29856974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
    Parikh RB; Cronin AM; Kozono DE; Oxnard GR; Mak RH; Jackman DM; Lo PC; Baldini EH; Johnson BE; Chen AB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):880-7. PubMed ID: 24867533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
    Yang H; Li M; Mei T
    Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.